Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1975 Apr 1;141(4):753-60.

Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses

Comparative Study

Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses

A Coutinho et al. J Exp Med. .

Abstract

Spleen cells from C3H/HeJ mice fail to respond with polyclonal antibody synthesis to mitogenic concentrations of lipopolysaccharide (LPS) which are optimal for activating spleen cells from a high-responder strain (B10.5M). This unresponsiveness is selective for LPS, since C3H/HeJ cells respond as normals to another B-cell mitogen, purified protein derivative of tuberculin. Spleen cells from low-responder mice also fail to mount a specific anti-NNP plaque-forming cell (PFC) response, when challenged in vitro by NNP-LPS. However, C3H/HeJ cells develop normal responses to another thymus-independent hapten conjugate, DNP-AECM-Ficoll. C3H/HeJ mice fail to mount a specific anti-LPS antibody response, when challenged in vivo with doses of soluble LPS which are fully immunogenic for the high-responder strain. However, C3H/HeJ mice develop normal direct and indirect PFC responses to LPS, when challenged with a thymus-dependent form of the immunogen. These results are interpreted as indicating as absolute requirement for functional mitogenicity of the antigen, in the induction of specific thymus-independent antibody responses.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1974 May 1;139(5):1354-60 - PubMed
    1. Nat New Biol. 1972 Dec 13;240(102):198-200 - PubMed
    1. J Exp Med. 1974 Nov 1;140(5):1147-61 - PubMed
    1. Scand J Immunol. 1974;3(2):133-46 - PubMed
    1. J Exp Med. 1974 Jan 1;139(1):74-92 - PubMed

Publication types